Alyeska Investment Group, L.P.

Position in ABCL — AbCellera Biologics Inc.

CIK 1453072 CHICAGO, IL

Position in ABCL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,133,629

-$4,912,817 QoQ

Shares Held

526,577

-79.7% QoQ

Ownership

0.172%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#25

of 150 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. ABCL ranks #48 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,133,629	526,577	-79.7%	Shares	Sole	2026-08-14
2026-03-31	$9,046,446	2,592,105	+417.0%	Shares	Sole	2026-05-15
2023-09-30	$2,306,233	501,355	+401.4%	Shares	Sole	2023-11-14
2022-12-31	$1,013,000	100,000	-86.6%	Shares	Sole	2023-02-14
2022-06-30	$7,951,843	746,652	-56.9%	Shares	Sole	2022-08-15
2022-03-31	$16,885,167	1,731,812	+22.2%	Shares	Sole	2022-05-17
2021-12-31	$20,268,290	1,417,363	+1873.5%	Shares	Sole	2022-02-14
2021-09-30	$1,439,272	71,820	-68.1%	Shares	Sole	2021-11-15
2021-06-30	$4,950,000	225,000	+12.5%	Shares	Sole	2021-08-16
2021-03-31	$6,792,000	200,000	-20.0%	Shares	Sole	2021-05-17
2020-12-31	$10,060,000	250,000	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.